Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Macular Edema, Retinal Vein Occlusion

In brief

This is a Phase 3, multicenter, randomized, masked, controlled, parallel group study of 12 months duration in treatment naïve subjects with RVO.

Key facts

Study ID
NCT02980874
Run by
Clearside Biomedical, Inc.
People needed
460
Starts
2017-01-31
Expected to finish
2018-12-10
Last updated by the study team
2021-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.